‘Nanodecoy’ Therapy Binds and Neutralizes SARS-CoV-2 Virus
Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19. By mimicking the receptor that the virus binds to rather than targeting the virus itself, nanodecoy therapy could remain effective against emerging variants of the virus.
Inhalation Therapy Shows Promise Against Pulmonary Fibrosis in Mice, Rats
A new study from North Carolina State University shows that lung stem cell secretions – specifically exosomes and secretomes – delivered via nebulizer, can help repair lung injuries due to multiple types of pulmonary fibrosis in mice and rats. The work could lead to more effective, less invasive treatment for human pulmonary fibrosis sufferers.
EVENTS & PRESENTATIONS
Feb. 26-27, 2019
CED Life Science Conference 2019
Raleigh Convention Center
May 17-22, 2019
American Thoracic Society International Conference 2019
Kay Bailey Hutchison Convention Center